These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer's disease mechanisms. Longo FM; Yang T; Knowles JK; Xie Y; Moore LA; Massa SM Curr Alzheimer Res; 2007 Dec; 4(5):503-6. PubMed ID: 18220511 [TBL] [Abstract][Full Text] [Related]
5. Neurotrophin-based strategies for neuroprotection. Longo FM; Massa SM J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S13-7. PubMed ID: 15665408 [TBL] [Abstract][Full Text] [Related]
6. Neurotrophin receptor-based strategies for Alzheimer's disease. Longo FM; Massa SM Curr Alzheimer Res; 2005 Apr; 2(2):167-9. PubMed ID: 15974914 [TBL] [Abstract][Full Text] [Related]
7. Targeting neurotrophin receptors in the central nervous system. Mocchetti I; Brown M CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):71-82. PubMed ID: 18289034 [TBL] [Abstract][Full Text] [Related]
8. Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases. Janssens J; Lu D; Ni B; Chadwick W; Siddiqui S; Azmi A; Etienne H; Jushaj A; van Gastel J; Martin B; Maudsley S Vitam Horm; 2017; 104():263-311. PubMed ID: 28215298 [TBL] [Abstract][Full Text] [Related]
9. Advances in small molecules promoting neurotrophic function. Price RD; Milne SA; Sharkey J; Matsuoka N Pharmacol Ther; 2007 Aug; 115(2):292-306. PubMed ID: 17599430 [TBL] [Abstract][Full Text] [Related]
10. Small molecule modulation of p75 neurotrophin receptor functions. Longo FM; Massa SM CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):63-70. PubMed ID: 18289033 [TBL] [Abstract][Full Text] [Related]
12. Small molecule activators of the Trk receptors for neuroprotection. Webster NJ; Pirrung MC BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S1. PubMed ID: 19090982 [TBL] [Abstract][Full Text] [Related]
13. Neuronal and nonneuronal expression of neurotrophins and their receptors in sensory and sympathetic ganglia suggest new intercellular trophic interactions. Wetmore C; Olson L J Comp Neurol; 1995 Feb; 353(1):143-59. PubMed ID: 7714245 [TBL] [Abstract][Full Text] [Related]
14. Development of pharmacological agents for targeting neurotrophins and their receptors. Saragovi HU; Gehring K Trends Pharmacol Sci; 2000 Mar; 21(3):93-8. PubMed ID: 10689362 [TBL] [Abstract][Full Text] [Related]
15. NGF and the treatment of Alzheimer's disease. Olson L Exp Neurol; 1993 Nov; 124(1):5-15. PubMed ID: 8282080 [TBL] [Abstract][Full Text] [Related]
16. Functional mimetics of neurotrophins and their receptors. Peleshok J; Saragovi HU Biochem Soc Trans; 2006 Aug; 34(Pt 4):612-7. PubMed ID: 16856874 [TBL] [Abstract][Full Text] [Related]
17. Peptide mimetics of neurotrophins and their receptors. Skaper SD Curr Pharm Des; 2011; 17(25):2704-18. PubMed ID: 21728978 [TBL] [Abstract][Full Text] [Related]
18. Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm. Josephy-Hernandez S; Jmaeff S; Pirvulescu I; Aboulkassim T; Saragovi HU Neurobiol Dis; 2017 Jan; 97(Pt B):139-155. PubMed ID: 27546056 [TBL] [Abstract][Full Text] [Related]
19. A neurotrophic rationale for the therapy of neurodegenerative disorders. Saragovi HU; Hamel E; Di Polo A Curr Alzheimer Res; 2009 Oct; 6(5):419-23. PubMed ID: 19874265 [TBL] [Abstract][Full Text] [Related]
20. Monitoring signaling by the p75(NTR) receptor utilizing a caspase-3 activation assay amenable to small-molecule screening. Bradshaw JM; Nguyen L; Wallace W; Li C; Sauer JM; Bard F; Bova MP Assay Drug Dev Technol; 2012 Aug; 10(4):353-64. PubMed ID: 22663019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]